Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL21806629

NCCCOCCOCCOCCCNC(=O)c1cc2ccc(OCC(=O)NCCOCCOCCOCCOCCC(=O)NCCc3ccc(O)cc3)cc2oc1=O.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AKR1B10 O60218 10/20 0.49
AKR1B1 P15121 9/20 0.49
AKR1A1 P14550 2/20 0.47
CBR1 P16152 2/20 0.47
AKR1C4 P17516 2/20 0.47
AKR1C3 P42330 2/20 0.47
AKR1C2 P52895 2/20 0.47
AKR1C1 Q04828 2/20 0.47
CA12 O43570 3/20 0.46
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
CA4 P22748 3/20 0.46
CA5A P35218 3/20 0.46
CA7 P43166 3/20 0.46
CA5B Q9Y2D0 3/20 0.46
MAOB P27338 2/20 0.42
NPC1 O15118 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21806631 0.93 CA12 (0.47) AKR1B10AKR1B1AKR1A1CBR1AKR1C4
SCHEMBL21806210 0.85 MAOB (0.46) AKR1B10AKR1B1CA12CA1CA2
Trifluoroacetic Acid SCHEMBL21806084 0.83 MAOB (0.48) AKR1B10AKR1B1AKR1A1CBR1AKR1C4
SCHEMBL25279702 0.81 AKR1B10 (0.75) AKR1B10AKR1B1AKR1A1CBR1AKR1C4
SCHEMBL25708668 0.80 AKR1B10 (0.77) AKR1B10AKR1B1AKR1A1CBR1AKR1C4
SCHEMBL25235579 0.79 AKR1B10 (0.64) AKR1B10AKR1B1AKR1A1CBR1AKR1C4
SCHEMBL21806302 0.79 MAOB (0.52) AKR1B10AKR1B1AKR1A1CBR1AKR1C4
SCHEMBL28636411 0.79 CA12 (0.44) AKR1B10AKR1B1AKR1A1CBR1AKR1C4
SCHEMBL21806177 0.78 AKR1B10 (0.41) AKR1B10AKR1B1AKR1A1CBR1AKR1C4
SCHEMBL21806085 0.77 MAOB (0.44) AKR1B10AKR1B1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3853214-A1 COUMARIN-BASED CROSSLINKING REAGENTS Ventana Medical Systems, Inc. (US) 2021-07-28 EP disclosed
WO-2020058339-A1 COUMARIN-BASED CROSSLINKING REAGENTS VENTANA MEDICAL SYSTEMS, INC. (US) 2020-03-26 WO disclosed